Kenneth Bloom, Ashley Van Zeeland, and Tom Wamberg

Human Longevity (HLI) has appointed Kenneth Bloom as its president, Ashley Van Zeeland as its chief technology officer, and Tom Wamberg as the president of the company's Insurance and Corporate Business Group.

Bloom originally joined HLI to head the oncology product area and to oversee laboratory operations. He now reports directly to Craig Venter, the CEO and co-founder. Bloom most recently worked at GE Healthcare, where he served as chief medical officer of In Vitro Diagnostics.

Van Zeeland originally joined HLI as part of the company's acquisition of Cypher Genomics, where she was co-founder and CEO. Prior to founding Cypher Genomics, she served as director of strategic partnerships at Scripps Translational Science Institute. 

Wamberg comes to HLI from Uniphy Health, a company he co-founded in 2013. He remains Uniphy Health's chairman.